These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pharmacologic approaches to treatment resistant depression: Evidences and personal experience. Tundo A; de Filippis R; Proietti L World J Psychiatry; 2015 Sep; 5(3):330-41. PubMed ID: 26425446 [TBL] [Abstract][Full Text] [Related]
5. Treatment-resistant depression: no panacea, many uncertainties. Adverse effects are a major factor in treatment choice. Prescrire Int; 2011 May; 20(116):128-33. PubMed ID: 21648180 [TBL] [Abstract][Full Text] [Related]
6. If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies. Connolly KR; Thase ME Drugs; 2011 Jan; 71(1):43-64. PubMed ID: 21175239 [TBL] [Abstract][Full Text] [Related]
8. [Antidepressants consumption in the global population in France]. Olié JP; Elomari F; Spadone C; Lépine JP Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of a refractory depressive episode]. Bougerol T Encephale; 1993 Aug; 19 Spec No 3():459-66. PubMed ID: 8299544 [TBL] [Abstract][Full Text] [Related]
10. [Therapy refractory depression]. Hatzinger M; Holsboer-Trachsler E Wien Med Wochenschr; 1999; 149(18):511-4. PubMed ID: 10637955 [TBL] [Abstract][Full Text] [Related]
11. The Expert Consensus Guideline Series. Treatment of depression in women. Altshuler LL; Cohen LS; Moline ML; Kahn DA; Carpenter D; Docherty JP; Postgrad Med; 2001 Mar; (Spec No):1-107. PubMed ID: 11500997 [TBL] [Abstract][Full Text] [Related]
12. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. Kane JM; Leucht S; Carpenter D; Docherty JP; J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142 [TBL] [Abstract][Full Text] [Related]
13. Assessing the comparative effectiveness of antidepressant therapies: a prospective clinical practice study. Parker G; Roy K; Wilhelm K; Mitchell P J Clin Psychiatry; 2001 Feb; 62(2):117-25. PubMed ID: 11247097 [TBL] [Abstract][Full Text] [Related]
14. [Biological treatment strategies of depression--psychopharmacology and non-pharmacological methods]. Hatzinger M Ther Umsch; 2010 Nov; 67(11):585-91. PubMed ID: 21043020 [TBL] [Abstract][Full Text] [Related]
15. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice. Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165 [TBL] [Abstract][Full Text] [Related]
16. [When depression does not end. Resistant depression: recent clinical and therapeutic aspects]. Gayetot D; Ansseau M; Triffaux JM Rev Med Liege; 2007 Feb; 62(2):103-11. PubMed ID: 17461300 [TBL] [Abstract][Full Text] [Related]
18. Severe depression: is there a best approach? Sonawalla SB; Fava M CNS Drugs; 2001; 15(10):765-76. PubMed ID: 11602003 [TBL] [Abstract][Full Text] [Related]
19. Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study. Alevizos B; Alevizos E; Leonardou A; Zervas I Psychiatriki; 2012; 23(2):143-8. PubMed ID: 22796912 [TBL] [Abstract][Full Text] [Related]